Differences in sleep quality between men and women start at puberty and continue to shift throughout pregnancy, menopause, ...

The landscape of medical artificial intelligence (AI) is experiencing unprecedented momentum. Since January, 2023, the number ...

Decades of research drive advancements in cancer care, shaping precision treatments and improving outcomes for patients ...

With the rise of advanced simulation and model-informed drug development (MIDD) techniques like digital twins, researchers ...

You can catch Trader Talk on Apple Podcasts, Spotify, YouTube, or wherever you get your podcasts. When a biotech startup ...

Takeda’s oral narcolepsy drug, oveporexton, has met the primary and secondary endpoints in two Phase III trials. The FirstLight (NCT06470828) and RadiantLight (NCT06505031) trials both met all their ...

Melbourne executive Nathan Smith will take the reins as CEO at NeuroScientific Biopharmaceuticals, bringing his strategic and ...

How AI, adaptive therapy, and precision tools are transforming lung cancer radiotherapy, making treatments faster, safer and ...

Many companies face FDA complete response letters due to ongoing chemistry, manufacturing, and controls, or CMC, and ...

A new study shows only one in five menopausal women have ideal scores on the American Heart Association’s health-assessment ...

Q2 2025 Earnings Call Transcript July 31, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is $1.46, expectations were $1.07. Operator: Good day, and welcome to the ...